These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 1868897

  • 1. Response of CFU-GM to increasing doses of rhGM-CSF in patients with aplastic anemia.
    Bacigalupo A, Piaggio G, Figari O, Tong J, Sogno G, Tedone E, Sette A, Ratto MR, Caciagli P, Badolati G.
    Exp Hematol; 1991 Sep; 19(8):829-32. PubMed ID: 1868897
    [Abstract] [Full Text] [Related]

  • 2. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin: colony-stimulating activity and lymphokine production.
    Tong J, Bacigalupo A, Piaggio G, Figari O, Sogno G, Marmont A.
    Exp Hematol; 1991 Jun; 19(5):312-6. PubMed ID: 1902792
    [Abstract] [Full Text] [Related]

  • 3. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC.
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [Abstract] [Full Text] [Related]

  • 4. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
    Wright DG, LaRussa VF, Salvado AJ, Knight RD.
    J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
    [Abstract] [Full Text] [Related]

  • 5. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A, Shibata A.
    Hematol Pathol; 1992 Apr; 6(3):143-53. PubMed ID: 1429342
    [Abstract] [Full Text] [Related]

  • 6. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 7. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 8. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A, Piaggio G, Podestá M, Raffo MR, Tedone E, Sogno G, Benvenuto F, Figari O, Grassia L, Bagnara GP.
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [Abstract] [Full Text] [Related]

  • 9. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
    Bacigalupo A, Piaggio G, Podestà M, Tong J, Pitto A, Figari O, Benvenuto F, Vassallo F, Tedone E, Grassia L, Van Lint MT, Gualandi F, Hoffman R.
    Haematologica; 1997 Jul; 82(2):133-7. PubMed ID: 9175313
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 16. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.
    Takahashi M, Aoki A, Mito M, Nikkuni K, Ohtsuka T, Saitoh H, Moriyama Y, Shibata A.
    Hematol Pathol; 1993 Nov; 7(3):153-8. PubMed ID: 8244908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.